-
Study aim
-
Preventive effect of intravenous ondansetron and paracetamol on shivering after spinal anesthesia
-
Design
-
Clinical trial with control group, with parallel groups, double-blind, randomized, phase 3 on 99 patients. Random allocation software was used for randomization.
-
Settings and conduct
-
This study will be conducted in Shariati Bandar Abbas Hospital in 2024 after the approval of the thesis and university ethics committee as a blind prospective clinical trial study on 99 patients aged 18 to 45 candidates for elective cesarean section. The participants were simple randomized construction and divided into three groups using random allocation software. The first group receives 15 mg/kg of Apotel (maximum dose1000 mg) in 100 cc of normal saline within 5 minutes before Spinal anesthesia. The second group receives 4 mg ondansetron in 100 cc of normal saline within 5 minutes before spinal anesthesia.The third group receives 100 cc of normal saline during the same time before spinal anesthesia.
During surgery and recovery, the degree of shivering, pain, nausea and vomiting will measured by a trained intelligence expert who does not know about the classification of patients.
-
Participants/Inclusion and exclusion criteria
-
Inclusion: aged 18-45 with ASA I, II are candidates for elective caesarean section with spinal anesthesia، gestational age ≥ 37 weeks .exclusion: contraindications, such as: high ICP, coagulation disorders, drug allergies, emergency cesarean section
-
Intervention groups
-
Three groups:
First group: recipient of 15 mg per kilogram of Apotel in 100 cc of normal salineThe second group: receiving 4 mg of ondansetron in 100 cc of normal salineThe third group: receiving 100 cc of normal saline (control group)
-
Main outcome variables
-
Study variables:
Pain intensity, chills, type of medicine, nausea and vomiting, amount of painkillers, blood pressure, heart rate, anti-chilling medicine